These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6587960)

  • 1. Amantadine in Tourette syndrome.
    Borison RL; Davis JM
    Curr Psychiatr Ther; 1983; 22():127-30. PubMed ID: 6587960
    [No Abstract]   [Full Text] [Related]  

  • 2. New pharmacological approaches in the treatment of Tourette syndrome.
    Borison RL; Ang L; Chang S; Dysken M; Comaty JE; Davis JM
    Adv Neurol; 1982; 35():377-82. PubMed ID: 6756088
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral effects of haloperidol in young Tourette syndrome patients.
    Bogomolny A; Erenberg G; Rothner AD
    Adv Neurol; 1982; 35():427-32. PubMed ID: 6959520
    [No Abstract]   [Full Text] [Related]  

  • 4. Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic administration.
    Allen RM
    Biol Psychiatry; 1982 Jun; 17(6):719-27. PubMed ID: 6179548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacotherapy of Tourette syndrome.
    Caine ED
    Int J Neurol; 1980; 14(1):123-6. PubMed ID: 6959970
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of Gilles de la Tourette Syndrome with haloperidol and clonidine].
    Fennig S; Bauer A; Kronnenberg Y
    Harefuah; 1984 May; 106(10):457-8. PubMed ID: 6590432
    [No Abstract]   [Full Text] [Related]  

  • 7. Tardive dyskinesia and chronic neuroleptic treatment of Tourette patients.
    Shapiro E; Shapiro AK
    Adv Neurol; 1982; 35():413. PubMed ID: 6959518
    [No Abstract]   [Full Text] [Related]  

  • 8. [Two cases of tardive Tourette syndrome].
    Yamauchi K; Ohmori T
    Seishin Shinkeigaku Zasshi; 2006; 108(5):459-65. PubMed ID: 16869393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment approaches in Gilles de la Tourette syndrome.
    Borison RL; Ang L; Hamilton WJ; Diamond BI; Davis JM
    Brain Res Bull; 1983 Aug; 11(2):205-8. PubMed ID: 6578865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine in tardive Tourette syndrome.
    Jaffe E; Trémeau F; Sharif Z; Reider R
    Biol Psychiatry; 1995 Aug; 38(3):196-7. PubMed ID: 7578666
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of medications on regulation of body temperature of patients with Tourette syndrome.
    Kessler AR
    J Child Neurol; 2004 Mar; 19(3):220-4. PubMed ID: 15119484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysphoric phenomena associated with haloperidol treatment of Tourette syndrome.
    Bruun RD
    Adv Neurol; 1982; 35():433-6. PubMed ID: 6959521
    [No Abstract]   [Full Text] [Related]  

  • 13. Treating Tourette syndrome with haloperidol: predictors of success.
    Schwabe MJ; Konkol RJ
    Wis Med J; 1989 Oct; 88(10):23-7. PubMed ID: 2815810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia in Tourette syndrome.
    Golden GS
    Pediatr Neurol; 1985; 1(3):192-4. PubMed ID: 3880404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonidine treatment of Tourette syndrome.
    Bruun RD
    Adv Neurol; 1982; 35():403-5. PubMed ID: 6959516
    [No Abstract]   [Full Text] [Related]  

  • 16. Added amantadine may diminish tardive dyskinesia in patients requiring continued neuroleptics.
    Freudenreich O; McEvoy JP
    J Clin Psychiatry; 1995 Apr; 56(4):173. PubMed ID: 7713860
    [No Abstract]   [Full Text] [Related]  

  • 17. [Polygraphic therapy control in Gilles de la Tourette syndrome--a case report].
    Seidel M; Gorynia I
    Psychiatr Neurol Med Psychol (Leipz); 1986 May; 38(5):265-74. PubMed ID: 3462755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of pharmacological approaches to therapy for Tourette syndrome.
    van Woert MH; Rosenbaum D; Enna SJ
    Adv Neurol; 1982; 35():369-75. PubMed ID: 6183950
    [No Abstract]   [Full Text] [Related]  

  • 19. Tourette syndrome associated with mental retardation: a single-subject treatment study with haloperidol.
    Rosenquist PB; Bodfish JW; Thompson R
    Am J Ment Retard; 1997 Mar; 101(5):497-504. PubMed ID: 9083606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [L-dopa-induced movement disorders in Parkinson disease. Amantadine improves dyskinesia].
    MMW Fortschr Med; 2001 May; 143 Suppl 2():93. PubMed ID: 11434272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.